Implications of Myocardial Bridge on Coronary Atherosclerosis and Survival

Roxana Oana Darabont1,2, Ionela Simona Vișoiu2, Ștefania Lucia Magda1,2

  • 1Department of Cardiology and Cardiovascular Surgery, University of Medicine and Pharmacy "Carol Davila", 37 Dionisie Lupu, 030167 Bucharest, Romania.

Insights

The presence of myocardial bridging (MB) on the left anterior descending artery (LAD) reduces atherosclerosis in coronary artery disease (CAD) patients. However, MB does not impact 10-year survival rates in these individuals.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Coronary artery disease (CAD) poses a significant global health challenge.
  • Myocardial bridging (MB) is a congenital anomaly where a segment of a coronary artery travels through heart muscle.
  • The impact of MB on atherosclerosis progression and patient outcomes remains an area of investigation.

Purpose of the Study:

  • To investigate the association between myocardial bridging (MB) and the extent of atherosclerosis in patients with coronary artery disease (CAD).
  • To evaluate the effect of MB on long-term survival in patients diagnosed with CAD.

Main Methods:

  • Retrospective analysis of 1920 patients undergoing coronary angiography for suspected CAD.
  • Comparison of atherosclerotic load (AL) and general atherosclerotic load (GAL) between patients with and without MB.
  • Assessment of 10-year survival rates in both groups.

Main Results:

  • Myocardial bridging (MB) was identified in 3.96% of patients, predominantly in the mid-left anterior descending artery (LAD).
  • Patients with MB exhibited significantly lower general atherosclerotic load (GAL) and atherosclerotic load (AL) in proximal and mid-LAD segments.
  • Multinomial logistic regression indicated that MB on the LAD is a protective factor against atherosclerotic lesions and significant stenosis.

Conclusions:

  • The presence of myocardial bridging (MB) on the left anterior descending artery (LAD) is associated with reduced atherosclerosis.
  • MB does not appear to influence 10-year survival outcomes in patients with coronary artery disease (CAD).

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
60
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
86
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
51
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.5K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
43
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
61